Clinical

Dataset Information

0

Effect of gabapentin capsules on nausea and vomiting


ABSTRACT: Intervention 1: In the intervention group: gabapentin capsule of 300 milligrams three times a day from one day Chemotherapy will be used until the end of the chemotherapy period. Intervention 2: In the control group, for the reduction of nausea and vomiting after chemotherapy, a routine of three drugs (dexamethasone, ranitidine and ketril) will be used.;Treatment - Drugs;Treatment - Drugs;In the intervention group: gabapentin capsule of 300 milligrams three times a day from one day Chemotherapy will be used until the end of the chemotherapy period.;In the control group, for the reduction of nausea and vomiting after chemotherapy, a routine of three drugs (dexamethasone, ranitidine and ketril) will be used Primary outcome(s): Nausea and vomiting. Timepoint: after intervention. Method of measurement: By grade. Study Design: Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.

DISEASE(S): Malignant Neoplasm Of Stomach, Malignant Neoplasm Of Small Intestine, Malignant Neoplasm Of Colon, Malignant Neoplasm Of Rectosigmoid Junction, Malignant Neoplasm Of Rectum,C16, C17,Cancer

PROVIDER: 2493651 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2225674 | ecrin-mdr-crc
| 2033103 | ecrin-mdr-crc
| 2685822 | ecrin-mdr-crc
| 2049587 | ecrin-mdr-crc
| 2105952 | ecrin-mdr-crc
2020-04-18 | GSE148835 | GEO
2022-02-19 | GSE196900 | GEO
2011-11-28 | E-GEOD-17992 | biostudies-arrayexpress
2011-02-06 | E-MEXP-3029 | biostudies-arrayexpress
| PRJDB11253 | ENA